A Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) in India (MK-7962-037)

Clinical trial NCT07600723 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07600723
Sponsor: Merck Sharp & Dohme LLC
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2026-11-04
Primary completion: 2028-04-03
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.